StrainX Bioworks raises $13 million to scale microbial fermentation from India

StrainX Bioworks, a synthetic biology and microbial fermentation company founded by IIT Delhi alumni Akshay Mittal and Alok Malaviya, has raised $13 million as it emerges from two years of stealth-mode development. The company has built an integrated biotechnology platform spanning strain engineering, fermentation, process scale-up, and product development, and has demonstrated fermentation at the 10,000-liter scale with plans to reach 100,000-liter operations. Its team has grown to more than 100 scientists, engineers, and operators.

"StrainX stood out to us because it combines two things that are rarely found together in biotech: serious science and sharp business execution. The company is not just building molecules in a lab. It is building the team, platform, manufacturing capability and partnerships needed to take Indian bio-manufacturing to the world."

—Brij Bhushan, Managing Partner, Prime Venture Partners

• The round was led by Prime Venture Partners and Leo Capital, with participation from Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures, and WindT (IIT Delhi) Angels.
• The investment marks Good Startup's first deal in India; the fund is known for backing technically driven, biology-focused companies.
• StrainX targets the global food, nutraceuticals, and personal care industries and plans to collaborate with international food and ingredient partners for commercialization.
• The company aligns with the Indian government's increasing emphasis on deep-tech, advanced manufacturing, and biotechnology as national priorities.